REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, published by Springer, is a leading journal in the field of endocrinology, diabetes, and metabolism, with an impressive Q1 ranking in both categories as of 2023. With an ISSN of 1389-9155 and E-ISSN 1573-2606, this journal serves as a vital resource for researchers, clinicians, and students seeking comprehensive reviews that address the latest advancements and interdisciplinary approaches in the management of endocrine and metabolic disorders. Operating from the Netherlands, it features articles that are rigorously peer-reviewed and is notable for its significant impact factor reflected in its Scopus rankings, placing it in the top percentile of its categories. Although it does not currently offer open access, it provides critical insights applicable to both basic and clinical settings, making it indispensable for those dedicated to enhancing patient outcomes in endocrine health.

Hormones - International Journal of Endocrinology and Metabolism, published by Springer International Publishing AG, is a vital resource within the field of Endocrinology, Diabetes, and Metabolism. Since its inception in 2005, this journal has made significant contributions to the understanding of hormonal mechanisms and their implications across various medical disciplines. With a current impact factor that places it in the Q3 category for Endocrinology and the Q2 category for miscellaneous Medicine – as indicated by its Scopus rankings – it stands out as a reputable platform for cutting-edge research and clinical findings. Although it operates under a subscription model, the journal's comprehensive scope encompasses basic and applied scientific studies, making it essential reading for researchers, clinicians, and students alike. The journal is headquartered in Germany with a strong commitment to promoting scholarly communication and knowledge dissemination within its specialized fields through the year 2024 and beyond.

The International Journal of Endocrinology is a premier peer-reviewed journal, published by HINDAWI LTD, focusing on the rapidly evolving fields of endocrinology, diabetes, and metabolism. Since its establishment in 2009, the journal has embraced an Open Access model, ensuring that cutting-edge research is accessible to a global audience without barriers. With an impressive Scopus rank placing it within the top quartiles of related fields, it ranks #103 in Endocrinology, Diabetes and Metabolism, showcasing its significant contribution to the ongoing discourse in these areas. The journal's scope includes original research, reviews, and clinical studies that advance understanding and treatment strategies for endocrine disorders. By bridging the gap between research, clinical practice, and patient care, the International Journal of Endocrinology serves as an essential resource for researchers, practitioners, and students dedicated to the field of endocrinology. Addressed from its headquarters in the United States, this journal not only contributes to academic advancement but also fosters international collaboration in addressing key challenges in endocrinology.

Therapeutic Advances in Endocrinology and Metabolism is a premier open-access journal published by SAGE Publications Ltd that has established itself as a leading platform for research in the field of endocrinology, diabetes, and metabolism. With a commitment to disseminating high-quality research, the journal aims to advance our understanding of therapeutic interventions and innovations in the management of endocrine disorders. Since its inception in 2010, it has garnered a strong reputation, attaining a Q1 quartile ranking in 2023 in its category and boasting a respectable Scopus rank of #53 out of 244, positioning it within the 78th percentile. As an open-access journal since 2019, Therapeutic Advances in Endocrinology and Metabolism ensures that valuable research findings are accessible to a global audience, fostering collaboration and knowledge sharing among researchers, clinicians, and students alike. The journal's multifaceted objectives encompass the publication of original research, reviews, and clinical studies that contribute to the evolving dialogue surrounding endocrine health. By delivering timely and robust content, it serves as an indispensable resource for those striving to make significant contributions to this vital area of medical science.

Hormone Molecular Biology and Clinical Investigation, published by WALTER DE GRUYTER GMBH, is a pivotal journal within the realms of Endocrinology, Diabetes and Metabolism, and Molecular Biology, contributing significant insights to the field since its inception in 2010. With an ISSN of 1868-1883 and an E-ISSN of 1868-1891, this esteemed journal operates from its headquarters in Berlin, Germany. As a further testament to its growing influence, the journal has achieved respectable category quartile rankings in 2023, including Q3 in Endocrinology, Diabetes and Metabolism and Medicine (miscellaneous), alongside Q4 in Molecular Biology. While currently not open access, the journal is dedicated to disseminating high-quality research aimed at understanding hormone-related mechanisms, clinical applications, and the biochemical pathways that underpin human health. The rich variety of articles published in Hormone Molecular Biology and Clinical Investigation make it an invaluable resource for researchers, medical professionals, and students seeking to deepen their knowledge in these critical scientific areas.

Endocrinology Diabetes and Metabolism Case Reports, published by BIOSCIENTIFICA LTD, stands as a pivotal forum for sharing significant advancements and clinical case studies in the fields of endocrinology, diabetes, and metabolism. With an Open Access model initiated in 2013, this journal encourages the widespread dissemination and accessibility of research findings, promoting collaboration and innovation among scholars and healthcare professionals. Based in the United Kingdom, the journal features a focus on practical applications and unique case reporting that enriches the clinical understanding and management of complex endocrine disorders. Though currently it's ranked in the Q3 category for both Endocrinology, Diabetes and Metabolism and Internal Medicine, its ongoing commitment to quality and impact in clinical research makes it a valuable resource for researchers, professionals, and students alike, contributing to the advancement of knowledge in this critical medical domain.

Frontiers in Endocrinology, published by FRONTIERS MEDIA SA, is a leading open-access journal dedicated to the advancement of research in the fields of endocrinology, diabetes, and metabolism. Established in 2010, this journal has consistently demonstrated its academic excellence, achieving a prominent Q1 quartile ranking in its category as of 2023, and a commendable Scopus rank of #96 out of 244, placing it within the 60th percentile. The journal is committed to disseminating high-quality research that encompasses a wide range of topics within endocrinology, catering to the needs of a diverse audience that includes researchers, medical professionals, and students alike. With the critical goal of fostering knowledge-sharing and collaboration within the scientific community, Frontiers in Endocrinology is an invaluable resource for anyone looking to stay updated on the latest advancements and insights in endocrinology. It operates under a robust open-access model, ensuring that groundbreaking research is accessible to all, thereby driving innovation and progress in this essential field.

Annals of Pediatric Endocrinology & Metabolism, published by the Korean Society of Pediatric Endocrinology, is a vital resource for researchers, healthcare professionals, and students in the fields of endocrinology, diabetes, and pediatric health. With its commitment to open access since 2012, the journal facilitates the dissemination of groundbreaking research on pediatric endocrine disorders and metabolic diseases, ensuring that vital knowledge is accessible to a global audience. The journal maintains a reputable standing with a 2023 Scopus rank of #92 in Pediatrics and a Q3 quartile in Endocrinology, highlighting its impact on the field. Originating from South Korea, the journal fosters a collaborative network of researchers and advocates best practices in pediatric care through interdisciplinary studies. The Annals not only enhances scientific understanding but also emphasizes practical applications aimed at improving child health outcomes, making it an essential publication for academics and practitioners alike.

Archives of Endocrinology Metabolism is a distinguished open-access journal dedicated to advancing the field of endocrinology and metabolism. Published by SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIA, this journal has established itself as a vital platform for researchers, clinicians, and scholars since its inception in 2008. With an ISSN of 2359-3997 and E-ISSN of 2359-4292, it aims to disseminate high-quality research articles that explore the latest advancements in endocrinology, diabetes, and metabolism. As of 2023, it has achieved a commendable Q3 ranking in its field, demonstrating its relevancy and increasing visibility among peers. The journal's focus spans various sub-disciplines, including hormonal regulation, metabolic disorders, and innovative therapies, making it an essential resource for both emerging professionals and seasoned experts alike. With a rich repository of research from Brazil and beyond, Archives of Endocrinology Metabolism continuously seeks to contribute to the ongoing dialogue and collaboration within the global scientific community.

Cardiovascular Endocrinology & Metabolism is a leading open-access journal dedicated to advancing our understanding of the interconnections between cardiovascular health and endocrine functions. Published by Lippincott Williams & Wilkins, this journal serves as a vital resource for researchers and clinicians alike, providing timely insights into the intricate relationships between metabolic disorders and cardiovascular diseases. With an impressive impact factor and categorized in Q2 for both Cardiology and Cardiovascular Medicine as well as Endocrinology, Diabetes, and Metabolism, it holds a significant position within its respective fields. The journal has been fully open access since its inception in 2012, ensuring that critical research is accessible to a global audience. By fostering innovation and collaboration, Cardiovascular Endocrinology & Metabolism aims to promote better health outcomes and stimulate novel research directions, making it an essential resource for professionals striving to bridge the gaps between these two critical domains.